Expertise in

conditions

Masaaki Mori

Tokyo, JP

Clinical Trials:Currently Recruiting for 2 Trials

Expertise in

conditions

Tokyo, JP

Overview

Masaaki Mori practices in Tokyo, Japan. Mr. Mori is highly rated in 21 conditions, according to our data. His top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Respiratory Syncytial Virus (RSV) Infection, Kawasaki Disease, and Arthritis.

His clinical research consists of co-authoring 220 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Tokyo, Japan

Other Locations

Japan

St. Marianna University School Of Medicine, Kawasaki, Japan

Yushima, 1138510, Japan

Yokohama, Japan

Toyota, Japan

St. Marianna University Hospital
Kanagawa, Japan

Kanazawa, Japan

Keio, Japan

Bunkyo, Japan

Nagoya, Japan

Shinjuku, 1608582, Japan

Osaka, Japan

Yokosuka, Japan

Matsumoto, Japan

Fujisawa, Japan

Kagoshima, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)

Enrollment Status: Recruiting

Publish Date: February 10, 2026

Intervention Type: Drug

Study Drug: Baricitnib

Study Phase: Phase 3

Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.

Enrollment Status: Recruiting

Publish Date: February 10, 2026

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

A Multi-Center, Open-Label Trial to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Subcutaneously Administered Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

Enrollment Status: Active_not_recruiting

Publish Date: October 23, 2025

Intervention Type: Combination product

Study Drug: Belimumab

Study Phase: Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)

Enrollment Status: Completed

Publish Date: October 07, 2022

Intervention Type: Drug

Study Drug: Baricitnib

Study Phase: Phase 3

View 2 Less Clinical Trial

220 Total Publications

Clinical features and trends of severe paediatric group A streptococcal infections in Japan in the post-COVID-19 pandemic era.

Journal: Epidemiology and infection

Published: February 19, 2026

View All 220 Publications

Frequently Asked Questions about Masaaki Mori

Is Masaaki Mori a top-rated expert for Juvenile Idiopathic Arthritis (JIA)?

MediFind is an objective health platform that identifies experts based on real-world data. Masaaki Mori is classified as an Elite expert for Juvenile Idiopathic Arthritis (JIA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Masaaki Mori participate in research or clinical trials?

Yes. Masaaki Mori has published 220 articles and abstracts on conditions like Juvenile Idiopathic Arthritis (JIA). You can view a list of Masaaki Mori's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mori's expertise for a condition

ConditionClose